Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0895 per EA under NDC 16714064601. Its NADAC has been published 169 times since Apr 5, 2023.
Strength
30 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714064601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202467On Market Since
8/18/2022
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 169 times since Apr 5, 2023, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0895 per EA |
|---|---|
| All-time high | $0.1233 (Jan 10, 2024) |
| All-time low | $0.0828 (Nov 20, 2024) |
| 52-week high | $0.1019 |
| 52-week low | $0.0895 |
| Median price | $0.1024 |
| Average price | $0.1038 |
| Largest weekly change | +24.7% (Jun 19, 2024) |
| Weeks tracked | 169 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0895 per EA (NDC 16714064601), effective Jun 24, 2026.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 23.1%. It has been tracked across 169 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since Apr 5, 2023, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.1233 (Jan 10, 2024), with a median of $0.1024 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 16714064601) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification